FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Deferoxamine Mesylate (Hospira, Inc.), a generic iron chelator.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload
• Iron Poisoning

Drugs mentioned

• Desferal (Deferoxamine Mesylate)

Snippet

SUPPL AP for DEFEROXAMINE MESYLATE (DEFEROXAMINE MESYLATE)